International Stem Cell Corporation a California-based biotechnology company, today announced the conclusions from its study demonstrating the efficacy and safety of the hepatocyte-like cells derived from human parthenogenetic stem cells in a well-established animal model of a congenital liver disorder associated with bilirubin metabolism.
http://technews.tmcnet.com/news/2013/02/12/6918503.htm
http://technews.tmcnet.com/news/2013/02/12/6918503.htm
No comments:
Post a Comment